$
1.67
Change
0.00 0.00%
Volume
Volume 34,026
Mar 24, 2023, 3:59 p.m.
Quotes are delayed by 15 min
Previous close
$ 1.67
$ 1.67
Change
0.00 0.00%
Day low
Day high
$1.64
$1.71

52 week low
52 week high
$1.06
$3.10

Market cap
$102.42M
Average volume
46,567
P/E ratio
N/A
Rev. per Employee
N/A
EPS
-0.43
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on ONC
-
Oncolytics shares rise on data from Reolysin study
- Gabriel Madway
-
Oncolytics Biotech gets U.K. approval for Reolysin trial
- Gabriel Madway
-
Oncolytics Biotech gets U.K. approval for Reolysin trial
- Gabriel Madway
-
Oncolytics Biotech shares up 4.3% at $2.18
- Gabriel Madway
-
Oncolytics starts patient enrollment in Reolysin trial
- Gabriel Madway
-
Oncolytics starts patient enrollment in Reolysin trial
- Gabriel Madway
Other News on ONC
-
Espirito Santo's Surprise Loan Move
- The Wall Street Journal Interactive Edition
-
Consumer, Tech Stocks Weigh on Small-Caps
- The Wall Street Journal Interactive Edition
-
Pinnacle Airlines Gains Altitude
- The Wall Street Journal Interactive Edition
Press Releases on ONC
-
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
- Financial News Media
-
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
- Financial News Media
-
Oncimmune investment "will continue to pay dividends"
- TheNewswire.ca
-
Optimism Building for Advancing Pancreatic Cancer Treatment Therapies
- Financial News Media
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com